BSETrident Texofab LtdLowNeutral
Announced Mon, 26 May · 19:32 IST

Conversion of 96,287 warrants into 96,287 Equity shares of face value of Rs.10/- each.

Warrants ConvertedFund Raising View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Trident Texofab's board approved converting 96,287 warrants into an equal number of equity shares of Rs. 10 face value at an issue price of Rs. 70 per share (including a Rs. 60 premium). The allottees paid the balance 75% amount of Rs. 52.50 per warrant, totalling Rs. 50.55 lakh, to four non-promoter public category investors. These warrants were originally allotted on December 23, 2024 on a preferential basis. After this conversion, the company's paid-up equity capital rises to Rs. 14.06 crore, comprising 1.40 crore equity shares. About 18.43 lakh warrants are still pending conversion, with holders having 18 months from the original allotment date to exercise.

Likely market impact

This is a routine warrant-to-equity conversion that increases the share count by 96,287 shares (small dilution, roughly 0.7%). For existing shareholders, expect mild dilution; the incoming Rs. 50.55 lakh strengthens the company's equity base, but the impact on stock price is likely negligible given the small size.